"MeijiSeikaファルマ" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonMeiji Seika Pharma’s Nacubactam to Be Featured in 10 Presentations at ESCMID Global 2026 — Includ...
Meiji Seika Pharma: Investment In Vaccine Developer To Advance Universal Immunity Platform - Puls...
Meiji Seika Pharma: Investment In Vaccine Developer To Advance Universal Immunity Platform Pulse 2.0
Meiji Seika Pharma Invests in Lyric Bio for Next-Generation Human Immunoglobulin Manufacturing - ...
Meiji Seika Pharma Invests in Lyric Bio for Next-Generation Human Immunoglobulin Manufacturing Business Wire
How Meiji Seika Pharma Aims to Lead Global Health With New Vaccines and Antibiotics - The Worldfolio
How Meiji Seika Pharma Aims to Lead Global Health With New Vaccines and Antibiotics The Worldfolio
Meiji Seika Pharma Establishes Singapore Hub To Expand ASEAN Pharmaceutical Business - BioPharma ...
Meiji Seika Pharma Establishes Singapore Hub To Expand ASEAN Pharmaceutical Business BioPharma APAC
Japan's Meiji Seika Pharma invests in Centivax to develop next-gen universal vaccine platform - B...
Japan's Meiji Seika Pharma invests in Centivax to develop next-gen universal vaccine platform BioSpectrum Asia
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform - Bi...
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform BioSpace
Meiji Seika Pharma Initiates Phase I Clinical Trial in Australia Evaluating ME3241, an Anti-PD-1 ...
Meiji Seika Pharma Expands Global Reach with Breakthroughs in Antibiotics, Vaccines and Emerging ...
Meiji Seika Pharma Expands Global Reach with Breakthroughs in Antibiotics, Vaccines and Emerging Markets The Worldfolio
Meiji Seika Pharma’s Morcamilast (ME3183) was Granted Orphan Medicinal Product Designation by the...
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery - ...
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery Business Wire
Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary "Taiwan Meiji Pharma Co...
Meiji Seika Pharma: Adcock Ingram Pharma Private Limited Completes Construction of a New Manufact...
Meiji Seika Pharma Invests in MPM BioImpact’s New Technologies and Virology Strategy - Business Wire
Meiji Seika Pharma Invests in MPM BioImpact’s New Technologies and Virology Strategy Business Wire
Meiji Seika Pharma: Adcock Ingram Ltd. in India to Build a New Manufacturing Facility to Enhance ...
Meiji Seika Pharma: Adcock Ingram Ltd. in India to Build a New Manufacturing Facility to Enhance Its CMO Business Business Wire
Meiji Seika Pharma Opens New Office in Boston Area to Pursue Investment Opportunities in Innovati...
Meiji Seika Pharma Opens New Office in Boston Area to Pursue Investment Opportunities in Innovative Drugs and Technologies Business Wire
Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan - BioSpectrum...
Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan BioSpectrum Asia
Japan's Meiji Seika to build $20.1M manufacturing plant in India - Fierce Pharma
Japan's Meiji Seika to build $20.1M manufacturing plant in India Fierce Pharma
Meiji Seika Pharma files suit against lawmaker over 'unfounded' vaccine claims - The Japan Times
Meiji Seika Pharma files suit against lawmaker over 'unfounded' vaccine claims The Japan Times
Osivax Secures Strategic Funding to Accelerate the Development of its Influenza Vaccine Candidate...
Osivax Secures Strategic Funding to Accelerate the Development of its Influenza Vaccine Candidates Business Wire
Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility - Co...
Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility Contract Pharma
A novel anti-PD-1 agonist antibody with immunosuppressive effect discovered through joint researc...
Meiji Seika Pharma Sets up a New Subsidiary in the US - Business Wire
Meiji Seika Pharma Sets up a New Subsidiary in the US Business Wire
Japan's Meiji Seika Pharma expands CMO business in India - BioSpectrum Asia
Japan's Meiji Seika Pharma expands CMO business in India BioSpectrum Asia
AstraZeneca taps JCR Pharmaceuticals, Daiichi Sankyo and other local pharmas to supply COVID-19 s...
AstraZeneca taps JCR Pharmaceuticals, Daiichi Sankyo and other local pharmas to supply COVID-19 shots to Japan Fierce Pharma
Drug company sues lawmaker over ‘bioweapon’ claim on vaccine - 朝日新聞
Drug company sues lawmaker over ‘bioweapon’ claim on vaccine 朝日新聞
Meiji Seika Pharma to build new facility in India for enhancing CMO biz - BioSpectrum Asia
Meiji Seika Pharma to build new facility in India for enhancing CMO biz BioSpectrum Asia
Tradition to drive innovation - The Worldfolio
Tradition to drive innovation The Worldfolio
Meiji Seika Pharma to build new facility in Bangalore to expand CMO business - Indian Pharma Post
Meiji Seika Pharma to build new facility in Bangalore to expand CMO business Indian Pharma Post
Japan's Meiji Seika Pharma buys Medreich - BioSpectrum Asia
Japan's Meiji Seika Pharma buys Medreich BioSpectrum Asia
Meiji Seika Pharma to launch two products from Santen Pharmaceutical Co., Ltd. in Indonesia - ANT...
Meiji Seika Pharma to launch two products from Santen Pharmaceutical Co., Ltd. in Indonesia ANTARA News
Meiji Group acquires Medreich for $290 million - Mint